Lilly Sues Accord Over Generic Lung Cancer Drug Alimta
Eli Lilly & Co. filed suit in Indiana federal court Friday alleging Accord Healthcare Inc. infringed its patent by applying for regulatory approval to make a generic version of lung cancer...To view the full article, register now.
Already a subscriber? Click here to view full article